BOSTON--(BUSINESS WIRE)--Amwell ® (NYSE: AMWL), a national telehealth leader, today announced the general availability of Converge™ for EHRs, adding built in EHR integration capabilities to the ...

Telehealth company Amwell notched peak research and development costs related to its Converge platform in its earnings results released aftermarket Wednesday as the company focused on developing and ...

COVID-19 has forever changed healthcare and consequently has led to a massive acceleration in the use of telehealth. We saw telehealth usage skyrocket in 2020, with Amwell’s research showing that 22% ...

In 2014, Deloitte launched ConvergeHealth, as part of a multimillion-dollar investment in life sciences and health care analytics that included a set of new platforms and informatics services. The ...

Amwell missed Wall Street expectations on earnings and revenue for the first quarter as it worked to expand its new virtual care platform Converge, resulting in rising R&D costs and customer churn.

Bank of America Securities analyst Allen Lutz maintained a Buy rating on American Well (AMWL – Research Report) yesterday and set a price target of $2.30. Allen Lutz’s rating for American Well’s stock ...

Converge wins recognition from UCSF, Chilmark Research and MassTLC as it moves into general availability “We are thrilled to see both the industry and our clients responding so favorably to Converge, ...